This compound is a pharmaceutical intermediate used in the synthesis of active pharmaceutical ingredients. It is a salt-like mixture containing an aromatic ring and carboxylic acid functional group, characterized by moderate polarity and lipophilicity.
Escopo do conteúdo: As informações desta página dizem respeito à identificação química e aos contextos de fornecimento industrial, pesquisa e produção. Não constituem alegação terapêutica, aconselhamento médico ou instruções de uso de medicamentos.
Procurando comprar este composto?
Publique um pedido de compra gratuito, sem necessidade de conta. Ele chega aos fornecedores deste produto e as respostas vão direto para o seu e-mail.
Benzyl (3S,4S)-3-(2-bromoacetyl)-4-ethylpyrrolidine-1-carboxylate
Pharmaceutical intermediate for synthesis
Benzyl (3R,4S)-3-(2-bromoacetyl)-4-ethylpyrrolidine-1-carboxylate
pharmaceutical intermediate
Benzyl (3S,4R)-3-ethyl-4-(3H-imidazo(1,2-a)pyrrolo-(2,3-e)pyrazin-8-yl)pyrrolidine-1-carboxylate
pharmaceutical intermediate for API synthesis
MK-1026 Intermediate-Biayrl Ether
pharmaceutical intermediate
4-[(Acetyloxy)methyl]-5-methyl-1,3-dioxol-2-one
pharmaceutical intermediate
4-(5,5-DIMETHYL-1,3,2-DIOXABORINAN-2-YL)-1H-PYRAZOLE
Pharmaceutical intermediate
(3R,4S)-1-((Benzyloxy)carbonyl)-4-ethylpyrrolidine-3-carboxylic acid
Pharmaceutical intermediate
Sulfoxonium, (2-((3R,4S)-4-ethyl-1-((phenylmethoxy)carbonyl)-3-pyrrolidinyl)-2-oxoethyl)dimethyl-, inner salt, rel-
Pharmaceutical intermediate for synthesis
N-cyclohexylcyclohexanamine;4-ethyl-1-phenylmethoxycarbonylpyrrolidine-3-carboxylic acid
XQYOTLNAUVFWHH-UHFFFAOYSA-N
CCC1CN(CC1C(=O)O)C(=O)OCC2=CC=CC=C2.C1CCC(CC1)NC2CCCCC2
—
Procurando comprar este composto?
Publique um pedido de compra gratuito, sem necessidade de conta. Ele chega aos fornecedores deste produto e as respostas vão direto para o seu e-mail.